Filters
Hikma remains a constituent of the FTSE4Good Index
Press Release, Corporate
Hikma launches Morphine Sulfate Injection, USP, in a prefilled syringe in the US
Press Release, Product
Supporting communities globally: Highlights from our 2025 Global Volunteer Campaign
Story, Responsibility
Meet Farah Alasali, Senior Officer in our Social Responsibility team based in Jordan. Hear what she has to say about lif...
Story, Life at Hikma
Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US
Press Release, Product
Hikma publishes its 2024 Sustainability Report reinforcing commitment to global access to medicines
Press Release, Corporate
Hikma R&D Analytical Research Innovation. Meet Samuel Cook
Story, Life at Hikma
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and dev...
Press Release, Corporate
Inspiring women of Hikma - Meet Judy Bock, Associate Director, Quality Assurance
Story, Leadership
Hikma launches Methylene Blue Injection, USP in the US
Press Release, Product
Meet Ashanti Finley, Specialist in the People Function team at Berkeley Heights, US. Hear what she has to say about life...
Story, Life at Hikma
Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement
Story, Leadership
Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US
Press Release, Product
Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable
Press Release, Corporate